Зиновьева Марина Валерьевна

Кандидат биологических наук


Старший научный сотрудник (Группа генной иммуноонкотерапии)

Эл. почта: mzinov@ibch.ru

Избранные публикации

  1. Zinovyeva MV, Nikolaev LG, Kondratyeva LG, Vinogradova TV, Sverdlov ED (2018). Correlation between Expression of KLF5 and ZEB1 Transcription Factor Genes in Pancreatic Cancer. Dokl Biochem Biophys 481 (1), 219–221
  2. Kondratyeva LG, Chernov IP, Zinovyeva MV, Egorov VI, Kopantzev EP, Sverdlov ED (2018). Heterogeneous Expression of Embryonal Development Master Regulator SOX9 in Patients with Pancreatic Cancer. Dokl Biochem Biophys 481 (1), 208–211
  3. Kuzmich AI, Zinovyeva MV, Potapov VK, Kostina MB, Sverdlov ED (2018). CRISPR/CAS Targeted in vivo Genome Modification for Studying the Functional Role of Genomic Regulatory Elements in Health and Carcinogenesis. Mol. Gen. Microbiol. Virol. 33 (1),
  4. Kondratyeva LG, Chernov IP, Zinovyeva MV, Kopantzev EP, Sverdlov ED (2017). Expression of master regulatory genes of embryonic development in pancreatic tumors. Dokl Biochem Biophys 475 (1), 250–252
  5. Abjalimov IR, Zinovyeva MV, Nikolaev LG, Kopantzeva MR, Kopantzev EP, Sverdlov ED (2017). Expression of transcription factor genes in cell lines corresponding to different stages of pancreatic cancer progression. Dokl Biochem Biophys 475 (1), 267–270
  6. Alekseenko IV, Kuzmich AI, Pleshkan VV, Tyulkina DV, Zinovyeva MV, Kostina MB, Sverdlov ED (2016). The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors? Mol Biol (Mosk) 50 (6), 906–921
  7. Zinovyeva MV, Kostina MB, Chernov IP, Kondratyeva LG, Sverdlov ED (2016). KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers. Russ. J. Bioorganic Chem. 42 (6), 606–611
  8. Alekseenko IV, Kuzmich AI, Pleshkan VV, Tyulkina DV, Zinovyeva MV, Kostina MB, Sverdlov ED (2016). The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors? Mol Biol 50 (6), 799–811
  9. Pleshkan VV, Alekseenko IV, Tyulkina DV, Kyzmich AI, Zinovyeva MV, Sverdlov ED (2016). Fibroblast activation protein (FAP) as a possible target of an antitumor strategy. Mol. Gen. Microbiol. Virol. 31 (3), 125–134
  10. Zinovyeva MV, Kuzmich AI, Monastyrskaya GS, Sverdlov ED (2016). The role of FOXA subfamily factors in embryonic development and carcinogenesis of the pancreas. Mol. Gen. Microbiol. Virol. 31 (3), 135–142
  11. Skvortsova YV, Kondratieva SA, Zinovyeva MV, Nikolaev LG, Azhikina TL, Gainetdinov IV (2016). Intragenic locus in human PIWIL2 gene shares promoter and enhancer functions. PLoS One 11 (6), e0156454
  12. Gainetdinov IV, Kondratieva SA, Skvortsova YV, Zinovyeva MV, Stukacheva EA, Klimov A, Tryakin AA, Azhikina TL (2016). Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas. Oncotarget 7 (16), 22439–22447
  13. Zinovyeva MV, Kostina MB, Monastyrskaya GS, Sass AV, Filyukova OB, Vinogradova TV, Kopantzev EP, Sverdlov ED (2015). Genetic markers for lung and esophagus common precursor cells in human development. Dokl Biochem Biophys 463 (1), 203–208
  14. Rozhkova AV, Zinovyeva MV, Sass AV, Zborovskaya IB, Limborska SA, Dergunova LV (2014). Expression of sphingomyelin synthase 1 (SGMS1) gene varies in human lung and esophagus cancer. Mol Biol 48 (3), 340–346
  15. Alekseenko IV, Kuzmin DV, Pleshkan VV, Zinovyeva MV, Sverdlov ED (2013). Cytotoxicities of cytosine deaminase and herpes simplex virus thymidine kinase genes in melanoma cells are not affected by the promoter strength. Russ. J. Bioorganic Chem. 39 (6), 665–667
  16. Demidyuk IV, Shubin AV, Gasanov EV, Kurinov AM, Demkin VV, Vinogradova TV, Zinovyeva MV, Sass AV, Zborovskaya IB, Kostrov SV (2013). Alterations in Gene Expression of Proprotein Convertases in Human Lung Cancer Have a Limited Number of Scenarios. PLoS One 8 (2), e55752
  17. Alekseenko IV, Zinovyeva MV, Pleshkan VV, Sverdlov ED (2012). Gene targeting in melanoma therapy: Exploiting of surface markers and specific promoters. Biopolymers and Cell 28 (1), 3–13
  18. Pleshkan VV, Zinovyeva MV, Sverdlov ED (2011). Melanoma: Surface markers as the first point of targeted delivery of therapeutic genes in multilevel gene therapy. Mol Biol 45 (3), 375–391
  19. Kashkin KN, Musatkina EA, Komelkov AV, Sakharov DA, Trushkin EV, Tonevitsky EA, Vinogradova TV, Kopantzev EP, Zinovyeva MV, Kovaleva OV, Arkhipova KA, Zborovskaya IB, Tonevitsky AG, Sverdlov ED (2011). Genes Potentially Associated with Resistance of Lung Cancer Cells to Paclitaxel. Dokl Biochem Biophys 437 (1), 105–108
  20. Pleshkan VV, Alekseenko IV, Zinovyeva MV, Vinogradova TV, Sverdlov ED (2011). Promoters with cancer cell-specific activity for melanoma gene therapy. Acta Naturae 3 (2), 13–21
  21. Shubin AV, Demidyuk IV, Kurinov AM, Demkin VV, Vinogradova TV, Zinovyeva MV, Sass AV, Zborovskaya IB, Kostrov SV (2010). Cathepsin D messenger RNA is downregulated in human lung cancer. Biomarkers 15 (7), 608–613
  22. Kopantzev EP, Vayshlya NA, Kopantseva MR, Egorov VI, Pikunov M, Zinovyeva MV, Vinogradova TV, Zborovskaya IB, Sverdlov ED (2010). Cellular and molecular phenotypes of proliferating stromal cells from human carcinomas. Br J Cancer 102 (10), 1533–1540
  23. Zinovyeva MV, Monastyrskaya GS, Kopantzev EP, Vinogradova TV, Kostina MB, Sass AV, Filyukova OB, Uspenskaya NY, Sukhikh GT, Sverdlov ED (2010). Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development. Dis Esophagus 23 (3), 260–270
  24. Kudriavtseva AV, Anedchenko EA, Oparina NY, Krasnov GS, Kashkin KN, Dmitriev AA, Zborovskaya IB, Kondratjeva TT, Vinogradova EV, Zinovyeva MV, Kopantsev EP, Senchenko VN (2009). Expression of FTL and FTH genes encoding ferritin subunits in lung and renal carcinomas. Mol Biol 43 (6), 972–981
  25. Anedchenko EA, Dmitriev AA, Krasnov GS, KondratEva OO, Kopantsev EP, Vinogradova TV, ZinovEva MV, Zborovskaya IB, Polotsky BE, Sacharova OV, Kashuba VI, Zabarovsky ER, Senchenko VN (2008). Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer. Mol Biol 42 (6), 859–869
  26. Kopantzev EP, Monastyrskaya GS, Vinogradova TV, Zinovyeva MV, Kostina MB, Filyukova OB, Tonevitsky AG, Sukhikh GT, Sverdlov ED (2008). Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma. Lung Cancer 62 (1), 23–34
  27. Vayshlya NA, Zinovyeva MV, Sass AV, Kopantzev EP, Vinogradova TV, Sverdlov ED (2008). Increased expression of BIRC5 in non-small cell lung cancer and esophageal squamous cell carcinoma does not correlate with the expression of its inhibitors SMAC/DIABLO and PML. Mol Biol 42 (4), 579–587
  28. Slizhikova DK, Zinovyeva MV, Kuzmin DV, Snezhkov EV, Shakhparonov MI, Dmitriev RI, Antipova NV, Zavalova LL, Sverdlov ED (2007). Decreased expression of the human immunoglobulin J-chain gene in squamous cell cancer and adenocarcinoma of the lungs. Mol Biol 41 (4), 594–600
  29. Slizhikova DK, Zinoveva MV, Kuzmin DV, Snezhkov EB, Shakhparonov MI, Dmitriev RI, Antipova NV, Zavalova LL, Sverdlov ED (2007). Decrease in expression of human J-chain in lung squamous cell cancer and adenocarcinoma. Mol Biol (Mosk) 41 (4), 659–665
  30. Mashkova TD, Oparina NY, Zinoveva OL, Kropotova ES, Dubovaya VI, Poltaraus AB, Fridman MV, Kopantsev EP, Vinogradova TV, Zinoveva MV, Laktionov KK, Kasymova OT, Zborovskaya IB, Sverdlov ED, Kisselev LL (2006). Transcription of TIMP3, DAPK1, and AKR1B10 in squamous-cell lung cancer. Mol Biol 40 (6), 945–951